Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Functional analysis of PEX13 mutation in a Zellweger syndrome spectrum patient reveals novel homooligomerization of PEX13 and its role in human peroxisome biogenesis.
[zellweger syndrome]
In
humans
,
the
concerted
action
of
at
least
13
different
peroxisomal
PEX
proteins
is
needed
for
proper
peroxisome
biogenesis
.
Mutations
in
any
of
these
PEX
genes
can
lead
to
lethal
neurometabolic
disorders
of
the
Zellweger
syndrome
spectrum
(
ZSS
)
.
Previously
,
we
identified
the
W
313
G
mutation
located
within
the
SH
3
domain
of
the
peroxisomal
protein
,
PEX
13
.
As
this
tryptophan
residue
is
highly
conserved
in
almost
all
known
SH
3
proteins
,
we
investigated
the
pathogenic
mechanism
of
the
W
313
G
mutation
and
its
role
in
PEX
13
interactions
and
functions
in
peroxisome
biogenesis
.
Here
,
we
report
for
the
first
time
that
human
PEX
13
interacts
with
itself
in
peroxisomes
in
living
cells
.
We
demonstrate
that
the
import
of
PTS
1
(
peroxisomal
targeting
signal
1
)
proteins
is
specifically
disrupted
when
homooligomerization
of
PEX
13
is
interrupted
.
Live
cell
FRET
microscopy
in
living
cells
as
well
as
co
-immunoprecipitation
experiments
reveal
that
the
highly
conserved
W
313
residue
is
important
for
self-association
of
PEX
13
but
is
not
required
for
interaction
with
PEX
14
,
a
well-established
interaction
partner
at
the
peroxisomal
membrane
.
Experiments
with
truncated
constructs
indicate
that
although
the
W
313
G
mutation
resides
in
the
C-
terminal
SH
3
domain
,
the
N-
terminal
half
is
necessary
for
peroxisomal
localization
,
which
in
turn
appears
to
be
crucial
for
homooligomerization
.
Furthermore
,
rescue
of
homooligomerization
in
the
W
313
G
mutant
cells
through
complementation
with
truncation
constructs
restores
import
of
peroxisomal
matrix
proteins
.
Taken
together
,
the
thorough
analyses
of
a
ZSS
patient
mutation
unraveled
the
general
cell
biological
function
of
PEX
13
and
its
mechanism
in
the
import
of
peroxisomal
matrix
PTS
1
proteins
.
Diseases
Validation
Diseases presenting
"first time"
symptom
achondroplasia
acute rheumatic fever
adrenal incidentaloma
adrenomyeloneuropathy
alpha-thalassemia
aniridia
aromatase deficiency
canavan disease
carcinoma of the gallbladder
cholangiocarcinoma
classical phenylketonuria
congenital adrenal hyperplasia
congenital toxoplasmosis
cowden syndrome
cushing syndrome
cutaneous mastocytosis
dedifferentiated liposarcoma
dentin dysplasia
dentinogenesis imperfecta
dracunculiasis
dystrophic epidermolysis bullosa
epidermolysis bullosa simplex
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
esophageal squamous cell carcinoma
fabry disease
familial mediterranean fever
gm1 gangliosidosis
harlequin ichthyosis
heparin-induced thrombocytopenia
hirschsprung disease
hodgkin lymphoma, classical
holt-oram syndrome
hydrocephalus with stenosis of the aqueduct of sylvius
junctional epidermolysis bullosa
kabuki syndrome
kallmann syndrome
liposarcoma
locked-in syndrome
lymphangioleiomyomatosis
malignant atrophic papulosis
megacystis-microcolon-intestinal hypoperistalsis syndrome
monosomy 21
neuralgic amyotrophy
oculocutaneous albinism
oligodontia
omenn syndrome
oral submucous fibrosis
papillon-lefèvre syndrome
pendred syndrome
phenylketonuria
primary effusion lymphoma
primary hyperoxaluria type 1
severe combined immunodeficiency
sneddon syndrome
triple a syndrome
trochlear dysplasia
von hippel-lindau disease
waldenström macroglobulinemia
well-differentiated liposarcoma
werner syndrome
wiskott-aldrich syndrome
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom